King Pharmaceuticals Inc Stock Analysis
| KG Stock | 25.26 0.26 1.04% |
KING PHARMACEUTICALS INC is overvalued with Real Value of 19.67 and Hype Value of 24.59. The main objective of KING PHARMACEUTICALS stock analysis is to determine its intrinsic value, which is an estimate of what KING PHARMACEUTICALS INC is worth, separate from its market price. There are two main types of KING PHARMACEUTICALS's stock analysis: fundamental analysis and technical analysis.
The KING PHARMACEUTICALS stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and KING PHARMACEUTICALS's ongoing operational relationships across important fundamental and technical indicators.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in KING PHARMACEUTICALS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. KING Stock Analysis Notes
About 100.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. KING PHARMACEUTICALS INC had 1:20 split on the 28th of May 2025. To find out more about KING PHARMACEUTICALS INC contact Bradford Ledbetter at 441-298-4900 or learn more at https://www.kestrelgroup.com.KING PHARMACEUTICALS Quarterly Total Revenue |
|
KING PHARMACEUTICALS INC Investment Alerts
| KING PHARMACEUTICALS is way too risky over 90 days horizon | |
| KING PHARMACEUTICALS appears to be risky and price may revert if volatility continues | |
| KING PHARMACEUTICALS INC was previously known as Maiden Holdings and was traded on NASDAQ Exchange under the symbol MHLD. | |
| KING PHARMACEUTICALS INC reports about 545.31 M in cash with (1.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58. | |
| Latest headline from MacroaxisInsider: Insider Trading |
KING PHARMACEUTICALS Thematic Classifications
In addition to having KING PHARMACEUTICALS stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | InsuranceUSA Equities from Insurance industry as classified by Fama & French |
KING Market Capitalization
The company currently falls under 'Small-Cap' category with a market capitalization of 248.49 M.KING Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.07 | |
| Return On Capital Employed | 0.04 | 0.04 | |
| Return On Assets | 0.07 | 0.07 |
Technical Drivers
As of the 20th of June, KING PHARMACEUTICALS secures the mean deviation of 6.95, and Risk Adjusted Performance of 0.203. KING PHARMACEUTICALS INC technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify KING PHARMACEUTICALS INC treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if KING PHARMACEUTICALS INC is priced more or less accurately, providing market reflects its recent price of 25.26 per share. Given that KING PHARMACEUTICALS INC has jensen alpha of 1.22, we recommend you to check KING PHARMACEUTICALS's last-minute market performance to make sure the company can sustain itself at some point in the future.KING PHARMACEUTICALS INC Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty.
KING PHARMACEUTICALS INC Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific KING PHARMACEUTICALS insiders, such as employees or executives, is commonly permitted as long as it does not rely on KING PHARMACEUTICALS's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases KING PHARMACEUTICALS insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Amtrust Financial Services, Inc. over three weeks ago Insider Trading |
KING PHARMACEUTICALS Predictive Daily Indicators
KING PHARMACEUTICALS intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of KING PHARMACEUTICALS stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
KING PHARMACEUTICALS Forecast Models
KING PHARMACEUTICALS's time-series forecasting models are one of many KING PHARMACEUTICALS's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary KING PHARMACEUTICALS's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About KING Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how KING PHARMACEUTICALS prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling KING shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as KING PHARMACEUTICALS. By using and applying KING Stock analysis, traders can create a robust methodology for identifying KING entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.07 | 0.07 | |
| Operating Profit Margin | 0.03 | 0.03 | |
| Net Profit Margin | 0.06 | 0.06 | |
| Gross Profit Margin | 0.35 | 0.37 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding KING PHARMACEUTICALS to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Complementary Tools for KING Stock analysis
When running KING PHARMACEUTICALS's price analysis, check to measure KING PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KING PHARMACEUTICALS is operating at the current time. Most of KING PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of KING PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KING PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of KING PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |